[{"id":"0a690816-3058-4f78-a5f7-3f90c27c2119","acronym":"","url":"https://clinicaltrials.gov/study/NCT02349022","created_at":"2021-01-18T11:10:24.023Z","updated_at":"2024-07-02T16:36:50.039Z","phase":"Phase 2","brief_title":"Comparison of PET With [89Zr]-Df-IAb2M and [111In]-Capromab Pendetide in the Detection of Prostate Cancer Pre-Prostatectomy","source_id_and_acronym":"NCT02349022","lead_sponsor":"ImaginAb, Inc.","biomarkers":" FOLH1","pipe":" | ","alterations":" B2M elevation • FOLH1 expression","tags":["FOLH1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e B2M elevation • FOLH1 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e 177Lu-capromab pendetide (CYT 500)"],"overall_status":"Completed","enrollment":" Enrollment 19","initiation":"Initiation: 01/01/2015","start_date":" 01/01/2015","primary_txt":" Primary completion: 04/01/2016","primary_completion_date":" 04/01/2016","study_txt":" Completion: 07/01/2016","study_completion_date":" 07/01/2016","last_update_posted":"2020-02-13"}]